comparemela.com

Latest Breaking News On - Post hoc subgroup - Page 1 : comparemela.com

Alkermes plc: Alkermes Highlights Data From Psychiatry Portfolio at Spring 2023 Scientific Conferences

? Clinical and Patient Experience Research Delivers Insights into Treatment for People Living with Schizophrenia or Bipolar I Disorder ? DUBLIN, May 16, 2023 /PRNewswire/ Alkermes

United statesSan franciscoSandy coombsGewinn nurMarisa borgasanoAripiprazole lauroxilCraig hopkinsonAntipsychotic treatments in community telepsychiatryAmerican society of clinical psychopharmacologyAlkermes incPatients livingPatient experience research delivers insightsInternational society for bipolar disordersSchizophrenia international research societyAlkermes pharma irelandAmerican psychiatric association

AbbVie Highlights Innovative Research From Its Rheumatology Portfolio at ACR Convergence 2021

Press release content from PR Newswire. The AP news staff was not involved in its creation.

United statesUpadacitinib monotherapyBrandee pappalardoAmerican college of rheumatologyRheumatology patient research registryAbbvie incDrug administrationAssociation between clinically meaningful improvements in patientEuropean commissionGroup analysisAssociation between clinically meaningful back pain improvementLaboratory abnormality profiles of upadacitinibExchange commissionAmerican collegeTerm safetyRheumatoid arthritis

AbbVie Highlights Innovative Research From Its Rheumatology Portfolio at ACR Convergence 2021

/PRNewswire/ AbbVie (NYSE: ABBV) today announced the presentation of new data on RINVOQ® (upadacitinib), SKYRIZI® (risankizumab) and HUMIRA® (adalimumab).

Upadacitinib monotherapyRheumatology patient research registryAssociation between clinically meaningful improvements in patientAssociation between clinically meaningful back pain improvementGroup analysisLaboratory abnormality profiles of upadacitinibTerm safetyRheumatoid arthritisCombination therapyAcross patient populationsResponse between upadacitinibResults throughSerologic statusClinical responsesPrior inadequate responseSub group analysis

vimarsana © 2020. All Rights Reserved.